Blog | HemaCare

HemaCare’s Top 10 Blog Posts of 2017

Jan 2, 2018 10:30:00 AM / by Stacy Matthews Branch, DVM, PhD

iStock-842491606.jpgAs each year passes, we realize new accomplishments in medical science. These advances are being achieved at faster and more significant ways as technology allows breakthroughs previously unimaginable. HemaCare has shared and helped realize many of these breakthroughs throughout 2017. Let’s countdown the best blogs of 2017, reflect on this new and promising medical knowledge, and prepare for another year of uncovering new paths to cell and gene-based medical therapies.

 

 

 

 

10. Will a Stem Cell Cure for HIV Be a Reality?

Researchers studied the use of a patient’s own stem cellsto confer resistance to the HIV virus. This entailed obtaining the patient’s stems and genetically modifying them to become HIV resistant.

9. Allergy Triggering IgE Gets a New Identity: Aggravating Inflammation in Lupus Patients

A study in people with lupus erythematosus revealed that patients with the condition had higher levels of self-reactive IgE than those who do not have lupus. Therefore, IgE may be a viable target for the treatment of lupus.

8. Double-Edged Stem Cell Transplantation to Treat Lupus

A therapy combining hematopoietic and mesenchymal stem cell transplantation was shown to have better clinical results than using either cell type alone.

7. HemaCare Reports Strong, Profitable 2016 Results

Hemacare was pleased to announce global expansion and revenue increases. Plans to expand the cryopreserved cell product line and leukapheresis collections was made one of the priorities for 2017.

6.  Dendritic Cells in Treatment for Type 1 Diabetes

Dendritic cells were found to be important players in cell therapy for type 1 diabetes. Engineered dendritic cells targeting lymphoid sites of tolerance induction showed promise in counteracting the effects of deficient beta cell self-tolerance.

5. When It’s Really Bad: Bone Marrow Transplant for Crohn’s Disease? 

Drastic bone marrow transplantation in a patient with Crohn’s disease showed promise for difficult-to-treat, severe cases of the disease.

4. HemaCare and OneBlood Announce Innovative Partnership

HemaCare announced its partnership with the Florida-based not-for-profit blood center OneBlood. This collaboration increases HemaCare’s presence and reach in providing human-derived blood and tissue products for the research and clinical arenas.

3.  Leukopak Versus Buffy Coat

Leukopacks contain a higher and more reliable level of mononuclear cells than buffy coat collection. An average of 84% of white blood cells in HemaCare’s leukopaks are mononuclear cells.

2. Differences Between Primary Cells and Cell Lines

Primary cells are closer to the true living system and a less artificial cell-based system than cell lines.

Now for the absolute top article for 2017,

1. Analyzing Peripheral Blood Mononuclear Cell (PBMC) Samples from Clinical Trials

Research to determine how to offset the effects of long-term cryopreservation of PBMC cells showed that overnight resting of the cell samples improved T cell responsiveness.

 

HemaCare wishes all of you a healthy, prosperous, and happy 2018!

      Subscribe Here!

      Posts by Topic

      see all

      Recent Posts